NEW YORK – Genomenon said Tuesday that it will integrate its Mastermind genomics literature search engine into OmniTier's CompStor Insight platform, a specialized appliance for tertiary analysis of next-generation sequencing data. The partnership will give CompStor Insight users a list of published articles relevant to their searches and help them quickly find the scientific evidence in Mastermind, the companies said.
CompStor Insight is targeted at research and clinical users who are looking to understand the relationships between multiple genomes, including those who are trying to diagnose rare diseases. OmniTier, which has twin headquarters in Milpitas, California, and Rochester, Minnesota, introduced the product around the virtual American Society of Human Genetics conference in October.
"With this partnership, OmniTier's CompStor Insight users will be able to directly link out to relevant Mastermind articles when investigating specific variants of interest," Mike Klein, CEO of Ann Arbor, Michigan-based Genomenon, said in a statement. Klein said that the integration will reduce the cost of genomic analysis for "mainstream" clinical diagnosis and genomic screening facilities.
"Our customers have been asking us to partner with Genomenon to give them access to the world's most comprehensive source for genomic variant literature," added OmniTier CEO Hemant Thapar. "With this partnership, we will bring the power of Mastermind variant evidence lookup to CompStor's fast, low-cost, on-premises-based variant interpretation."
Genomenon said that Mastermind support will be available to all CompStor Insight users later this month.